منابع مشابه
The Case for Every-Other-Day Dialysis.
Until daily dialysis becomes widely available, we believe that hemodialysis patients would benefit enormously from every-other-day dialysis (EODD), which may be implemented both by home patients and in centers. Benefits of EODD over the routine, three-times-weekly schedule would include decreased mortality after the weekend interval without dialysis; increased weekly dose of dialysis, resulting...
متن کاملEvery Other Day Gentamicin Injection in Experimental Pyelonephritis in Rats: Risk of Scar Formation
Background: Urinary tract infection in children may cause renal scar formation, which can be prevented by early and appropriate treatment. Recent studies showed that single daily injection of gentamycin can produce best effect without increasing the side effects. The aim of this study was to evaluate the rate of renal scar formation when new regime (every other day gentamicin injection) used fo...
متن کاملA pill for every ill.
To the Editor: Dr Lip1 and The HOPE investigators2 again sing the praises of ACE inhibitors (“the pill for every ill”)—this time in the regression and prevention of ECG-LVH. The numerous “non– blood pressure” properties of ACE inhibition are elegantly described in Dr Lip’s editorial, as the benefits noted were not simply explained by blood pressure reduction. However, the blood pressure story m...
متن کاملComparison of Daily versus Every Other Day Treatment Regimen of Levamisole to Control Recurrence in the Childhood Idiopathic Nephrotic Syndrome
Background Idiopathic nephrotic syndrome is a kidney involvement that causes edema and heavy proteinuria with severe complications if the treatment is started late. The present study aimed to assess the efficacy of Levamisole in the daily versus every other day treatment regimen to control recurrence in Childhood Idiopathic Nephrotic Synd...
متن کاملTreating desires not diseases: a pill for every ill and an ill for every pill?
My first recollection of modern pharmaceuticals is from the winter of 1942–1943, when my younger sister, suffering from pneumonia, was treated with M&B693 from May and Baker Pharmaceuticals (http://www.may-baker.com/). The doctor and my mother sat up all night nursing her through ‘the crisis’, which she survived. Most families, at least in the rich world, have similar stories to tell of how med...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Reproduction
سال: 1968
ISSN: 1470-1626,1741-7899
DOI: 10.1530/jrf.0.0160137